Ann: Incannex to Acquire APIRx Pharmaceuticals, page-64

So much to pull out of this....

-pretty clear that IHL has no intention of selling any IP now and want to take their products to the market alone with APIRx patented delivery tech...?

-interesting that the furthest advanced clinical trial APIRx has in its shed is targeting I.B.S.....one of IHL's target markets...common ground?

-$93mil for $400bil TAM in IP.....I would like to see APIRx's financials....perhaps struggling to finance trials and found a common goal alliance to push forward

-nearly all trials are stage one for APIRx.....costly to run them all to fruition...?

much more as well....

a great long term view for me....

onwards and upwards!!!!!